Somewhat Positive Media Coverage Somewhat Unlikely to Impact AVEO Pharmaceuticals (NASDAQ:AVEO) Stock Price

Share on StockTwits

News coverage about AVEO Pharmaceuticals (NASDAQ:AVEO) has been trending somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. AVEO Pharmaceuticals earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned news coverage about the biopharmaceutical company an impact score of 48.4853259561468 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the news stories that may have effected Accern’s rankings:

AVEO Pharmaceuticals stock traded down $0.27 during mid-day trading on Thursday, hitting $2.36. The company’s stock had a trading volume of 3,438,539 shares, compared to its average volume of 1,712,653. The firm has a market capitalization of $310.24, a price-to-earnings ratio of -14.75 and a beta of 1.32. AVEO Pharmaceuticals has a 1 year low of $0.55 and a 1 year high of $4.24. The company has a debt-to-equity ratio of -0.45, a quick ratio of 1.56 and a current ratio of 1.56.

A number of equities analysts have commented on AVEO shares. B. Riley reissued a “buy” rating and set a $5.00 target price on shares of AVEO Pharmaceuticals in a report on Tuesday, January 16th. Zacks Investment Research raised AVEO Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Tuesday, January 9th. Finally, BidaskClub cut AVEO Pharmaceuticals from a “sell” rating to a “strong sell” rating in a report on Tuesday, January 9th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $4.05.

ILLEGAL ACTIVITY NOTICE: This article was first reported by BBNS and is the sole property of of BBNS. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at https://baseballnewssource.com/2018/04/05/aveo-pharmaceuticals-aveo-getting-somewhat-positive-press-coverage-analysis-shows/2028075.html.

AVEO Pharmaceuticals Company Profile

AVEO Pharmaceuticals, Inc, a biopharmaceutical company, develops targeted therapies for cancer and related diseases. The company's pipeline of product candidates include Tivozanib, a vascular endothelial growth factor (VEGF) to optimize VEGF blockade; Ficlatuzumab, a hepatocyte growth factor (HGF) inhibitory antibody, which has completed Phase II trial that inhibits the activity of the HGF/c-Met pathway; and AV-203, an anti-ErbB3 specific monoclonal antibody that has completed a Phase I dose escalation study.

Insider Buying and Selling by Quarter for AVEO Pharmaceuticals (NASDAQ:AVEO)

Receive News & Ratings for AVEO Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVEO Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand
Yankees Former Ace Ron Guidry Says Luis Severino Will Break His Records
Yankees Former Ace Ron Guidry Says Luis Severino Will Break His Records
Ruptured Biceps Tendon Ends Miguel Cabrera’s Season
Ruptured Biceps Tendon Ends Miguel Cabrera’s Season
Dodgers Getting Big Unexpected Lift from Three Players
Dodgers Getting Big Unexpected Lift from Three Players


Leave a Reply

 
© 2006-2018 BBNS.